How to Handle Nosebleeds in Children

Epistaxis (nosebleeds) in children is a common occurrence. It tends to occur more frequently during hot summer months and dry winter seasons, particularly in some children who experience recurrent nocturnal epistaxis. Many parents become understandably anxious about this issue. So, how should epistaxis in children be managed?

Management of Epistaxis in Children

Treatment of pediatric epistaxis may involve pharmacologic interventions, local management of the bleeding site, blood sampling, complete blood count (CBC), and coagulation studies. Pharmacologic therapy includes topical application of hemostatic agents into the nasal cavity, as well as systemic administration—either orally or intravenously—of hemostatic drugs to reduce bleeding. For children with identifiable bleeding points within the nasal cavity, nasal packing using gelatin sponge, petrolatum-impregnated gauze, expandable nasal sponges, or water-filled balloons may be employed. If local packing fails or if the child is cooperative, localized electrocautery may be performed for hemostasis. Blood sampling, CBC, and coagulation testing are essential; only through these two key laboratory assessments can comprehensive screening and diagnostic evaluation be achieved. Should epistaxis stem from an underlying hematologic disorder, prompt referral to a hematologist for active management is crucial—otherwise, recurrent epistaxis will persist.

If the amount of bleeding is relatively minor, a cotton ball may be gently inserted into the affected nostril, and gentle bilateral pressure applied to the child’s nasal alae for approximately five minutes—this often achieves hemostasis. However, if epistaxis recurs frequently, the child must be evaluated by a healthcare provider. First, the nasal cavity should be examined for identifiable, recurrent bleeding vessels. Second, structural abnormalities—such as deviated nasal septum—should be assessed. Finally, routine laboratory evaluation—including CBC—is recommended to screen for potential hematologic disorders.

We recommend that patients undergo comprehensive evaluation to identify the underlying cause of epistaxis and initiate targeted, etiology-based treatment. We hope this information proves helpful.